Reply: GDNF poses troubling questions for doctors, drug maker [3]

John T. Slevin; Greg A. Gerhardt; Charles D. Smith; Don M. Gash; A. Byron Young

doi:10.1002/ana.20880

Reply: GDNF poses troubling questions for doctors, drug maker [3]

John T. Slevin
, Greg A. Gerhardt
, Charles D. Smith
, Don M. Gash
, A. Byron Young

Producción científica: Letter › revisión exhaustiva

5 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	989-990
Número de páginas	2
Publicación	Annals of Neurology
Volumen	59
N.º	6
DOI	https://doi.org/10.1002/ana.20880
Estado	Published - jun 2006

ASJC Scopus subject areas

Neurology
Clinical Neurology

Acceder al documento

10.1002/ana.20880

Otros archivos y enlaces

Citar esto

@article{ea0613ac421649e192ce8dbf73e6d157,

title = "Reply: GDNF poses troubling questions for doctors, drug maker [3]",

author = "Slevin, \{John T.\} and Gerhardt, \{Greg A.\} and Smith, \{Charles D.\} and Gash, \{Don M.\} and Young, \{A. Byron\}",

year = "2006",

month = jun,

doi = "10.1002/ana.20880",

language = "English",

volume = "59",

pages = "989--990",

number = "6",

}

TY - JOUR

T1 - Reply

T2 - GDNF poses troubling questions for doctors, drug maker [3]

AU - Slevin, John T.

AU - Gerhardt, Greg A.

AU - Smith, Charles D.

AU - Gash, Don M.

AU - Young, A. Byron

PY - 2006/6

Y1 - 2006/6

UR - https://www.scopus.com/pages/publications/33744819984

UR - https://www.scopus.com/pages/publications/33744819984#tab=citedBy

U2 - 10.1002/ana.20880

DO - 10.1002/ana.20880

M3 - Letter

C2 - 16718700

AN - SCOPUS:33744819984

SN - 0364-5134

VL - 59

SP - 989

EP - 990

JO - Annals of Neurology

JF - Annals of Neurology

IS - 6

ER -

Reply: GDNF poses troubling questions for doctors, drug maker [3]

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto